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Abstract
Structure-based protein design tests our understanding of the minimal determinants of protein
structure and function. Previous studies have demonstrated that placing zinc binding amino acids
(His, Glu, Asp or Cys) near each other in a folded protein in an arrangement predicted to be tetrahe-
dral is often sufficient to achieve binding to zinc. However, few designs have been characterized with
high-resolution structures. Here, we use X-ray crystallography, binding studies and mutation ana-
lysis to evaluate three alternative strategies for designing zinc binding sites with the molecular mod-
eling program Rosetta. While several of the designs were observed to bind zinc, crystal structures of
two designs reveal binding configurations that differ from the designmodel. In both cases, the mod-
eling did not accurately capture the presence or absence of second-shell hydrogen bonds critical in
determining binding-site structure. Efforts to more explicitly design second-shell hydrogen bonds
were largely unsuccessful as evidenced by mutation analysis and low expression of proteins engi-
neered with extensive primary and secondary networks. Our results suggest that improvedmethods
for designing interaction networks will be needed for creatingmetal binding sites with high accuracy.
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Introduction
Over 30% of nonredundant protein chains in the PDB contain bound
metal ions. These ions are often key tometalloproteins’ functions includ-
ing stability and folding (Tainer et al., 1992; O’Brien et al., 2015), intra-
cellular signaling (Burgoyne, 2007) and catalysis (Andreini et al., 2008).
Due to their prevalence and the range of functions that they can
provide, metal binding sites are appealing targets for protein design.
Previous studies have designed metal binding sites for functions in-
cluding allosteric control of an enzyme (Browner et al., 1994;
Dwyer et al., 2003), heavy-metal sequestration (Eskandari et al.,
2013; Zhou et al., 2014; Plegaria et al., 2015) and catalysis (Der
et al., 2012a; Zastrow et al., 2012). Since metal ions have only one
possible conformation to place in any given position and orientation,
they may also be a good starting point for computational design of lig-
and binding proteins. Furthermore, the coordination geometry of
many metals has been extensively studied (Tainer et al., 1992;
Karlin and Zhu, 1997; Auld, 2001).
Zinc ions are among the most common in metalloproteins, occur-
ring in 58% of known human metalloproteins, and serve a wide range
of functions (Azia et al., 2015). Many zinc binding sites provide struc-
tural stability, such as the sites that give superoxide dismutase (Nedd
et al., 2014) and zinc finger proteins (Matthews and Sunde, 2002)
their active conformations. Zinc binding can also induce oligomeriza-
tion (Derewenda et al., 1989) and conformational changes that lead to
signaling (Chen et al., 2014). About half of the eukaryotic zinc binding
proteins are enzymes, where zinc often acts as a catalytic cofactor. Ten
percent of enzyme-catalyzed reactions, including all six classes of en-
zyme, are thought to require zinc for at least one of their mechanisms
(Andreini and Bertini, 2012).
While structural zinc sites are most often buried and are coordi-
nated by four protein ligands, predominately histidines and cysteines,
catalytic sites are often solvent accessible and have only three coordin-
ating residues with one site occupied by a water molecule. These sites
are predominately coordinated by histidine, aspartate and glutamate
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residues, and cysteines are relatively uncommon (Auld, 2001; Andreini
and Bertini, 2012). First-shell residues are often stabilized by hydrogen
bondswith second-shell residues, most commonly Asp/Glu for catalyt-
ic histidines, backbone carbonyl groups for structural histidines and
backbone amide groups for Cys, Asp and Glu (Dudev et al., 2003;
Lin and Lim, 2004). These interactions have been shown to contribute
to bothmetal affinity and, in the case of zinc enzymes, catalytic activity
(Kiefer et al., 1995; Marino and Regan, 1999).
While efforts at metalloprotein design frequently yield metal bind-
ing, there are few examples of designs that have been structurally char-
acterized and have structures that closely match their designed models.
Such precision will be key for certain functional applications of metal-
loprotein design, most notably catalysis. Studies which directly graft a
native protein’s metal binding site onto a different scaffold (Müller and
Skerra, 1994) or insert a binding motif into a surface-exposed region
(Eskandari et al., 2013) have been successful in achievingmetal binding
but lack both models and crystal structures of designed proteins. Other
labs have designed sites rationally with no computational scoring. The
Pecoraro lab has designed binding sites for zinc andmercury in a trimeric
peptide (Zastrow et al., 2012) and for zinc in a single-chain three-helix
bundle (Plegaria et al., 2015); however, both studies lack structural mod-
els for their designs, so their precision cannot be determined.
Computational metalloprotein designs provide structural models
that can be used to evaluate the precision of designs when compared
with a crystal structure; however, many of these studies do not acquire
high-resolution structures of the designed proteins. The Regan group
has produced several successful zinc binding protein designs, including
designs containing second-shell interactions, but crystal structures for
those designs are not available (Regan and Clarke, 1990; Klemba and
Regan, 1995; Klemba et al., 1995;Marino and Regan, 1999). Designs
from the Hellinga group have likewise lacked structural studies
(Hellinga et al., 1991; Dwyer et al., 2003). Perhaps more informative
are examples in which structural information is obtained but shows
discrepancies with the designmodels. For instance, designed zinc bind-
ing sites from the Tezcan lab were found to bind residues that were not
anticipated and did not bind some of the designed residues (Salgado
et al., 2010). Similarly, the crystal structure of Zhou et al.’s uranyl
binding protein does not demonstrate coordination by two of the de-
signed residues (although this may be an artifact of crystallization con-
ditions) (Zhou et al., 2014), and the initial design model for the zinc
binding site of MID1 (Der et al., 2012b) includes a fourth histidine
that was not found to coordinate the metal in the crystal structure.
Even designs that would typically be considered successful, i.e.
those which specifically bind the intended metal with the intended re-
sidues and whose structures have a low RMSD to the design model,
often show slight differences in metal coordination that could make
such goals a considerable challenge. Notably, Mills et al. reported
using the RosettaMatch algorithm (Zanghellini et al., 2006) with
negative design states and a non-natural amino acid that forms a bi-
dentate interaction with zinc to design a binding site that only deviates
by 0.9 Å RMSD in the crystal structure from the designedmodel at the
binding site (Mills et al., 2013). Even this structure, however, is miss-
ing one predicted water molecule, and one ligand is bidentate instead
of monodentate as predicted. Even slight differences such as these
could have functional consequences. Coordinating water molecules
often participate in catalysis, particularly for zinc binding sites, and
any change in coordination will likely alter the electrostatic properties
of the metal ion, which would affect its ability to perform catalysis.
Therefore, only structures with all of the coordinating residues in
the correct rotamers and with the same basic coordination geometry
can truly be considered successful.
Here, we describe our approach for designing zinc binding proteins
in native protein scaffolds. Briefly, binding sites with three liganding
residues were first built in binding pockets from a library of scaffold
proteins (Rothlisberger et al., 2008) using the RosettaMatch algo-
rithm (Zanghellini et al., 2006) subject to geometric constraints.
Residues within 10 Å of the site were designed using Rosetta
(Leaver-Fay et al., 2011) to improve the site’s stability, and the result-
ing designs were filtered based on site geometry and other factors de-
scribed in more detail below. Three separate design approaches (called
phases) were performed with additional features being taken into ac-
count in each (Fig. 1). The outcomes of these results give further in-
sight into the challenges and factors that must be considered when
designing metalloproteins.
Materials and methods
Computational methods
For all designed zinc binding proteins, initial zinc sites were con-
structed using the RosettaMatch protocol (Zanghellini et al., 2006).
Briefly, we first obtained starting scaffolds by limiting a set of 85 en-
zyme scaffolds from previous studies to the 55 smallest scaffolds (<340
residues) (Jiang et al., 2008; Rothlisberger et al., 2008). These 55 scaf-
folds are listed in Supplementary Table SI. The open-source software
Fpocket (Le Guilloux et al., 2009) was then used to identify residue
positions in potential binding pockets within each of these scaffolds.
For each of these sets of residues, a search was conducted to determine
if a zinc binding site satisfying a provided set of geometric constraints
could be formed from residues within that set; these constraints varied
across the three design phases. Each of these constraints specified the
geometry of binding site residues relative to a potential ligand (in this
case, a zinc ion). For all possible residue positions within a candidate
binding pocket, all common rotamers of potential coordinating resi-
dues were placed, and the resulting zinc ion was stored in a six-
dimensional hash of its position and orientation. After this search
had been conducted for all constraints at all positions, the hash was
searched for bins that contain hits for all of the specified constraints,
indicating that the rotamers composing those hits could bind a ligand
with the position and orientation specified by that bin. If these rota-
mers did not clash with one another or with the protein backbone,
then the set of hits was output as a potential binding site (a ‘match’).
In each phase, after these binding sites had been constructed, the
geometry of the zinc binding site was scored (Der et al., 2012b) such
that a score of <2.0 is (on average) within 1 SD of the typical distances,
angles and dihedral angles for a zinc binding site. Designs were then re-
fined using backbone minimization and design of surrounding residues
as additional filters were applied in each phase as described below, and
a final set of designs was selected for testing by visual inspection.
Phase 1
In the first design phase, designed sites were required to contain three
coordinating residues in a tetrahedral arrangement; these sites in-
cluded three-histidine (HHH) sites; sites with two histidines and one
aspartate (HHD), glutamate (HHE) or cysteine (HHC); and sites
with one histidine and two cysteines (HCC). In each of these cases, in-
stead of a simple zinc ion, a zinc ion with a bound histidinewas used as
the test ligand to ensure that the designed binding site would have one
open coordination site. The ideal distance between the nitrogen and
zinc atoms was set to 2.10 Å with a 0.15 Å SD. The ideal angle
about the zinc ion was set to 109.5° (tetrahedral coordination), and
the ideal angle about the coordinating nitrogen was set to 120°. The
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zinc was further constrained to be planar with the histidine ring with a
120° torsion about the bond between the zinc ion and the histidine ni-
trogen; rather than using a second coordinating residue to determine
this torsion, it was measured with respect to the theoretical location of
a ligand if the coordination environment were perfectly tetrahedral.
Designs with zinc geometry scores <2.0 (within 1 SD of a typical
zinc coordination) were selected for refinement.
To refine the resulting models, we performed 10 runs of the Rosetta
enzyme design protocol EnzDes (Richter et al., 2011) per site. EnzDes
holds the designed coordinating residues fixed while allowing backbone
minimization of the remainder of the scaffold and designing and repack-
ing residues within specified distances of the zinc binding site. Both the
design and repacking shells specify two cutoff distances; residues that
have alpha carbons closer than the first cutoff to the ligand or with
alpha carbons closer than the second cutoff with side chains oriented
toward the ligand are included in that shell. The two design cutoffs
were set to 6 and 8 Å, and the two repacking cutoffs were set to 10
and 12 Å. Designs containing no clashes were then filtered to remove
sites containing rare rotamers of coordinating residues based on
Rosetta’s rotamer energy term (Shapovalov and Dunbrack, 2011) and
to remove designs containing buried unsatisfied polar atoms. An atom
was considered buried if it was inaccessible to a 1.2 Å probe; all such
polar atoms were required to have at least one hydrogen bond partner.
Phase 2
The second design phase required that each zinc binding site contain
three coordinating histidines, in this case using a free zinc ion as the
ligand. However, this set of designs further required that two of the
three coordinating histidines form hydrogen bonds with either the
carbonyl oxygen or a side chain oxygen from a neighboring residue.
These hydrogen bonding residues were again placed using the
RosettaMatch protocol as secondary matches. Briefly, matches were
initially identified using the coordinating residues as described
above. For each of these matches, possible rotamers of secondary
match residues were built off at each position; if that residue position
could form an interaction with the primary match residues that satis-
fies the match constraint, then it was stored. All possible sets of
second-shell interactions for a given primary match were output as
separate candidate binding sites. The ideal hydrogen bond distance be-
tween the donor and acceptor was set to 2.80 Å, and the angles about
the donor atoms were set to 109° for sp3-hybridized atoms and 120°
for sp2-hybridized atoms.
Designs were then refined using the following protocol: All resi-
dues within 10 Å of the binding site (excluding the residues placed
during the RosettaMatch protocol) were allowed to change rotamers
and identities. Since we had already made up to five mutations due to
the inclusion of second-shell residues in this phase, we wanted to min-
imize the number of mutations made to prevent destabilizing the na-
tive folds of the scaffolds. A 10-Å cutoff allowed changes in residues
which could potentially interact or clash with the new binding site
while maintaining the native sequence in more distal regions. Five
rounds of gradient-based minimization using Rosetta’s score12 score
function and ‘dfpmin’ minimizer were then performed on the torsion
angles of both the backbone and side chains of these residues. In each
case, sites were then filtered such that the total zinc geometry scorewas
<4.0 (indicating binding site geometry within 2 SDs of the mean), all
liganding atoms were <3.1 Å from the zinc ion and were within 30° of
Fig. 1Schematic of design strategies for first, second and third rounds of design. In the first set of designs (Phase 1), tetrahedral zinc binding siteswere designedwith
three coordinating residues and one open coordination site with at least two of the ligands on stable secondary-structure elements. In Phase 2, we designed two
second-shell hydrogen bonding residues in addition to three coordinating histidines. To increase the diversity of designed sites, Phase 3 allowed one of the
coordinating residues to be an aspartate or glutamate and removed the secondary-structure requirement for ligand residues, instead requiring all ligand
residues to have Cα B factor values of 30 or greater.
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the proper tetrahedral angles, the total score for the protein was <0
Rosetta energy units (REU) to avoid structures containing clashes,
the RMSD of the design to the starting scaffold was <2 Å, the
RMSD of the match residues was <1 Å and the solvent accessible sur-
face area of the zinc ion was at least 1 Å.
After refinement, sites were further filtered on the geometry of the
hydrogen bonds placed by the RosettaMatch protocol. All donor–ac-
ceptor distances were required to be <3.7 Å, and the Rosetta scores for
each of these hydrogen bonds were calculated and required to be <−1
REU. All match residues were required to be in favorable rotamers
(Rosetta rotamer scores of <6 REU), and the zinc geometry score
was required to be <2.5. Designs were further filtered to prohibit bur-
ied unsatisfied polar atoms within the designed portion of the protein,
to limit the total number of mutations to seven, to have at least two of
the three coordinating residues on stable secondary-structure elements
and to have no more than one glutamate or glutamine as a hydrogen
bond donor. Designs were chosen from the best-scoring 50% of the
structures that passed all of these filters.
Phase 3
Rather than requiring all three coordinating residues to be histidines,
the third design phase allowed one coordinating aspartate or gluta-
mate in the binding site. Distances, angles and dihedrals about the
zinc ion remained the same as for a coordinating histidine, and the
zinc ion was required to be in the plane of the carboxylate group.
Constraints were also added for possible hydrogen bond donors for
these residues; again, ideal hydrogen bond distances were set to
2.80 Å, and hydrogen bond angles remained 109° for sp3-hybridized
atoms and 120° for sp2-hybridized atoms.
Designs were then refined and filtered as in Phase 2 with the fol-
lowing exceptions: The filter on the secondary structure of coordinat-
ing residues was replaced with a filter that required the B factor of each
coordinating residue’s alpha carbon to be <30.0, and the filter limiting
the number of glutamates and glutamines in the binding site was re-
placed with a filter that limited the total number of lysines, arginines,
glutamates and glutamines in the binding site to two. The maximum
number of mutations allowed was increased to nine. During visual in-
spection, designs from different scaffold types were evaluated inde-
pendently so that at least one design from each representative
scaffold type was chosen.
Experimental methods
Protein expression and purification
DNA sequences for designed proteins were ordered as gBlocks gene
fragments from Integrated DNA Technologies (IDT) optimized for ex-
pression in Escherichia coli with a C-terminal stop codon. For all de-
signs, an N-terminal BamH1 restriction site and a C-terminal Sal1
restriction site were added to each design, and the designed proteins
were inserted into the pQE-80L vector with an N-terminal 6-His tag,
an MBP fusion and a TEV cleavage site. Phase 3 designs were inserted
into the same vector with noMBP fusion (pQE-80Lwith anN-terminal
6-His tag and TEV cleavage site). Plasmids were transformed into BL21
star cells (Phases 1 and 2) or BL21 cells (Phase 3) for expression. Cells
were initially grown at 37°C in 1.5 L LB broth containing 67 µg/ml
ampicillin to an OD of 0.6–0.8. Expression was then induced with
0.33 mM IPTG. Phase 1 designs were expressed at 30°C for 5 h, and
Phase 2 and 3 designs were expressed at 18°C for 18 h.
After expression, cultures were centrifuged at 12 000 rpm for
20 min to remove the growth media. Cell pellets were resuspended
in lysis buffer (10% glycerol, 20 mM Tris pH 8.0, 100 mM NaCl,
0.5 mM PMSF, 0.5 mMDTT, 1× leupeptin, 1× pepstatin, 1× bestatin)
and lysed by sonication. Two units each of DNase and RNase Awere
added to the lysates, and lysates were incubated at room temperature
for 15 min to remove nucleic acids. The lysates were then cleared
by centrifugation at 15 000 rpm for 30 min. Designed proteins
were purified from cleared lysates by immobilized-metal affinity chro-
matography (IMAC) with a 5 ml Ni-NTA HisTrap HP column (GE
Healthcare). Columns were equilibrated with 20 mM Tris pH 8.0,
100 mM NaCl, 25 mM imidazole (IMAC wash buffer) before
and after loading the lysate, and proteins were eluted with 20 mM
Tris pH 8.0, 100 mM NaCl and 500 mM imidazole (IMAC elution
buffer).
After elution, samples were treated with 5 mM EDTA to chelate
excess nickel ions and 0.05 mg/ml TEV protease to remove the poly-
histidine tag and/or MBP fusion. Samples were cleaved overnight
while being dialyzed into 20 mM Tris pH 8.0, 100 mM NaCl with
stirring. To remove the cleaved MBP and/or polyhistidine tags, the
samples were again purified by IMAC as before but were collected
in the flowthrough and wash steps. Samples were again treated with
5 mM EDTA and were concentrated to <2 ml for size exclusion chro-
matography on a Superdex-75 column (GEHealthcare, HiLoad 16/60
prep grade); during this process, they were exchanged either into
100 mM ammonium acetate pH 7.0 (crystallography buffer) or
100 mM ammonium acetate, 100 mMNaCl, pH 7.0 (sample buffer).
Fractions containing the purified protein were identified both by the
fractions’ absorbance at 280 nm and by SDS-PAGE, and pure frac-
tions were combined for subsequent experiments. Protein concentra-
tions were determined by their absorbance at 280 nm using molar
extinction coefficients calculated from their sequences (Gasteiger
et al., 2005).
Production of point mutants
Point mutations of all coordinating and second-shell residues in
Hinge2 were produced using a three-step PCR method. Both forward
and reverse primers were ordered containing each point mutation, and
the first and second halves of the gene were amplified separately using
these primers and the appropriate cloning primers. These fragments
were combined in a final PCR reaction to produce the full-length mu-
tant gene. All proteins were cloned and expressed as previously de-
scribed for Phase 3 designs, and gene sequences were verified by
sequencing.
Circular dichroism
All circular dichroism spectra and thermal melts were collected on a
JASCO J-815 CD spectrometer. Cell temperatures were controlled
by a JASCO Peltier device and water bath. CD spectra were measured
in sample buffer described above. ZE2 spectra were collected with
5 mM protein; ZE2 thermal denaturation curves and the spectra
and denaturation curves of Hinge2 and its point mutants were col-
lected with 15 mM protein. Spectra were measured from 190 to
250 nm, and thermal denaturationwasmeasured bymonitoring circu-
lar dichroism at 220 nm as the temperature was increased from 20 to
95°C at 3°C/min. Thermal denaturation was measured in the presence
and absence of 30 mM zinc sulfate.
Isothermal titration calorimetry
Zinc binding affinities were measured by isothermal titration calorim-
etry (ITC) on a MicroCal Auto-iTC200 instrument in UNC’s
Macromolecular Interactions Facility. All experiments were run at
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20°C with 20 2-µl injections of zinc into 200 µl protein in sample buf-
fer. ZE2 affinity measurements were carried out with a cell concentra-
tion of 40 µM ZE2 and a syringe concentration of 800 µM ZnSO4;
affinity measurements for Hinge2 and its mutants were performed at
∼50 µM protein and 1 mM ZnSO4.
X-Ray crystallography
For crystallization, ZE2 was exchanged into crystallization buffer as
described above and concentrated to 19 mg/ml. An equimolar concen-
tration of zinc sulfate was added prior to crystallization. Protein crys-
tals were initially grown in 0.1 mM succinate pH 6.0 and 22% PEG
3350 in a 96-well format at 20°C. These crystals were combined 1:1
with mother liquor from the samewell and were used as seed stock for
crystal seeding in a 24-well format under the same conditions. Crystals
in this format grew within 3–4 days. Cells from this screen were cryo-
protected in a 1:1 solution of 50% glycerol and mother liquor before
being stored in liquid nitrogen.
Spelter was stored in 10 mM ammonium acetate pH 7.0 prior to
crystallization at a 1:1:1 molar ratio with zinc sulfate and ubiquitin at
15 mg/ml total protein concentration. Protein crystals were grown in
0.22 M sodium iodide and 26% PEG 3350 at 4°C. Crystals took over
2 weeks to appear and were stored in liquid nitrogen prior to data col-
lection.
All diffraction data were collected at the Advanced Photon Source
(APS), Argonne National Laboratory (ANL), Argonne, IL. Data were
initially processed using the program HKL2000 (Otwinowski and
Minor, 1997). Molecular replacement into the starting scaffold pro-
tein was performed using Phaser (McCoy et al., 2007). The structure
was refined by alternating manual refinement using Coot (Emsley
et al., 2010) and anisotropic refinement using Refmac (Murshudov
et al., 2011).
Results and discussion
We searched potential ligand binding pockets in 55 monomeric scaf-
fold proteins for three-histidine zinc binding sites using the
RosettaMatch application (Zanghellini et al., 2006). During the initial
search, few three-histidine (HHH) sites were found; therefore, the
search was expanded to include HHD, HHE, HHC and HCC sites.
After filtering sites based on their zinc geometry score (described in
the Materials and Methods section), we identified 500 potential de-
signs (108 HHH sites, 193 HHD, 102 HHC and 98 HCC).
To resolve clashes with side chains of surrounding residues and
identify mutations that would stabilize our designs, we used the
EnzDes Rosetta protocol. This application allows small backbone
movements to the protein scaffold and repacks and designs side
chains within user-specified distances of the binding site. In this
protocol, we designed residues which had alpha carbons within
6 Å of the zinc ion or with alpha carbons within 8 Å of zinc with
side chains oriented toward the zinc ion; likewise, the two repacking
shells were set to 10 and 12 Å, respectively. Although it could poten-
tially design hydrogen bonds to the coordinating histidines, we found
that it very rarely did so; instead, its main function was to remove
clashes with neighboring residues. We performed 10 runs of this
protocol for each of the designed zinc sites, and these results were
then filtered to remove any models containing buried unsatisfied
polar atoms. The remaining sites were also filtered to remove designs
with rare rotamers for zinc-coordinating residues. We then used vis-
ual inspection of the remaining designs to select three (ZE1, ZE2 and
ZE3) with zinc binding sites in deep but accessible pockets. For these
designs, we also reverted any mutations that were not close to the
zinc coordination sphere.
All of our three selected designs were in α/β scaffolds; two of these
(ZE2 and ZE3) contained zinc binding sites in the beta barrel of TIM
barrel scaffolds (Table I), while ZE1’s zinc binding site sits within a
somewhat shallower cleft. ZE1 and ZE2 both contained three-
histidine zinc binding sites, whereas the ZE3 binding site consisted
of two histidines and one cysteine.
All three of the tested designs were solubly expressed in E. coli as
described in the Materials and Methods section. When the three de-
signs were purified by size exclusion, ZE1 and ZE2 eluted at the pre-
dicted monomeric sizes; however, ZE3 formed soluble aggregates
which eluted in the void volume and was thus excluded from further
analysis. ZE1 and ZE2 were initially tested for zinc binding by deter-
mining their change in thermal stability as determined by circular di-
chroism in the presence and absence of saturating zinc. ZE1was found
to denature at a lower temperature in the presence of zinc, indicating
that partial unfolding may be required for binding; therefore, it was
excluded from additional studies. ZE2 showed a 2.4°C increase in
its transition temperature in the presence of zinc, indicating that it suc-
cessfully binds zinc in the folded state (Fig. 2E).
Given this result, we next determined the affinity of ZE2 for zinc
using ITC (Fig. 2F). Our data indicate that ZE2 binds zinc in an exo-
thermic reaction with an affinity of 1.4 µM. However, we also ob-
served a second nonspecific binding event (KD ≈ 90 µM) in this
experiment. Since only one zinc ion was identified in the crystal struc-
ture of ZE2 (described below), it is unclear where this second binding
event occurs; ZE2 contains several patches of acidic residues which
could transiently bind zinc ions. However, due to the low affinity of
this interaction, it is unlikely to affect the results of our other assays.
The crystal structure of ZE2 was solved to 1.4 Å resolution using
molecular replacement into the native PDB scaffold (PDB ID 1a53).
We found that all of the designed zinc binding residues do participate
in the binding site (Fig. 2A and B); however, two of the coordinating
histidines are in different rotamers than were predicted in the design
model, allowing them to form stabilizing hydrogen bonds to two
second-shell residues (Fig. 2B). H210 has changed rotamers so that
its protonated ε nitrogen hydrogen bonds with the side chain of
E50, and the δ nitrogen H179 hydrogen bonds with the side chain
oxygen of N160. Both of these residues are also in a different tauto-
meric state than we predicted; H210 and H179 bind zinc with their δ
and ε nitrogen, respectively, instead of the ε and δ nitrogens as pre-
dicted. This adjustment has repositioned the binding site such that
the zinc ion is 3 Å from its predicted location. To accommodate this
motion, the flexible loop containing the third coordinating histidine
(H183) has shifted to complete the new binding site, placing its
alpha carbon 9 Å from its predicted location.
In our model, all of ZE2’s designed histidines were predicted to be
solvent-exposed with no hydrogen bonds to other protein residues;
however, in native proteins, such a configuration is very rare (Dudev
et al., 2003). We reasoned that explicit design of hydrogen bond part-
ners for these residues would stabilize the binding site and increase the
likelihood that our predicted structures would be accurate. Given this
result, we decided to incorporate these second-shell residues into our
next round of designs.
Our second design phase followed a similar procedure to the first;
however, we added secondary match constraints to build hydrogen
bond acceptors for two of the three coordinating histidines, and the
design models were further filtered on the geometry and energy of
the resulting hydrogen bonds. This procedure generated 144 722 po-
tential binding sites in 54 scaffolds, of which 7302 in 52 scaffolds
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Table I. Summary of zinc binding site designs and experimental results
Name Scaffold Scaffold type Mutations Zinc binding
residues
Second-shell
hydrogen
bond residues
Experimental outcome Zinc binding
affinity
Phase 1 ZE1 4fua Hydrolase-like (α/β) G37A H92, H94, H155 N/A Destabilized by zinc ND
ZE2 1a53 TIM barrel (α/β) K109A, E158G, N179H, R181A, L183H, E209A,
S210H
H179, H183,
H210
N/A Soluble, binds zinc 1.4 µM
ZE3 1dl3 TIM barrel (α/β) L130G, E158H, M79C, R181S, E209H H7, C7, H79 N/A Soluble aggregates ND
Phase 2 1473 1icm Lipocalin-like (Beta barrel) L36S, E51H, R56H, V60H, Y70N H51, H56, H60 S36, N70 Soluble aggregates ND
225 1q7f 6-bladed beta propeller A32N, R79H, T120H, V163S, V164S, I207H H79, H120, H207 N32, S164 Did not express ND
255 1m4w Jelly roll (Beta sandwich) Y78H, W80H, E87H, Y89N, D169G H78, H80, H87 N89, S126 Soluble aggregates ND
339 1f5j Jelly roll (Beta sandwich) Y81H, W83H, E90H, Y92T, S130T H81, H83, H90 D92, T130 Soluble aggregates ND
548 1lbm TIM barrel (α/β) K5H, A25G, F55H, V57H, Q81I, I101E, L124I,
A165N, D167G
H5, H55, H57 E10, N165 Soluble aggregates ND
1032 1suu 6-bladed beta propeller V186T, K187H, D239H, I241T, V287A, S288H,
V289A
H187, H239,
H288
T24, T186 Aggregated after
cleavage
ND
289 2h13 6-bladed beta propeller K21R, D61H, C103H, N105D, F232H H61, H103, H232 S60, D105 Soluble aggregates ND
Phase 3 Alpha1 1ovk Lysozyme-like (α+β) T21Q, N101A, Q105E, M106D, W118H, T122H,
R125G
E105, H138,
H142
N21, D106 Did not express ND
AlphaBeta1 6cpa Hydrolase-like (α/β) R71A, E72H, R127H, E163Q, H196D, E270H,
F279H
H72, H127, H279 Q163, D196 Did not express ND
TIM1 1igs TIM barrel (α/β) W7E, S55H, P56A, S57G, F87N, R181E, L186H H55, E181, H186 E7, S210 Low expression, bound
zinc
∼50 µM
TIM2 1tml 7-stranded TIM barrel (α/β) F42E, N46T, Q53H, L57K E42, H44, H53 T46, K57 Did not express ND
Hinge1 1abe Periplasmic binding protein (α/β) W16F, D88H, M107Q, T146H, R150M, M203S,
N204H, T207Q
H88, H146, H204 E107, D231 Expressed, bound zinc 6.5 µM
Hinge2 1gca Periplasmic binding protein (α/β) F16D, N91G, T110H, D154E, N256H, Q261E,
Y295C
H110, H256,
E261
D16, E154 Expressed, bound zinc 1.1 µM
Beta1 1cbs Lipocalin-like (Beta barrel) F15H, L18S, L19A, A32H, A36S, V76E H15, H32, E76 S18, S36 Did not express ND
Beta2 1cbs Lipocalin-like (Beta barrel) F15A, L18E, A32D, A36H, T56N, V76H D32, H36, H76 E18, N56 Did not express ND
Beta3 1ifc Lipocalin-like (Beta barrel) L36S, E51H, F55S, R56H, I58E, V60H H51, H56, H60 S36, S55 Soluble aggregates ND
Beta4 1cbs Lipocalin-like (Beta barrel) F15A, L18Q, A32D, A36H, T56N, V76H D32, H36, H76 E18, N56 Did not express ND
Pocket1 1f5j Jelly roll (Beta sandwich) N43E, L45D, Q128R, E180H, Y182H E43, H180, H182 D45, R128 Soluble aggregates ND
Pocket2 1m4w Jelly roll (Beta sandwich) Y78H, W80H,Y89D, I127D, D169G H78, H80, E87 D89, D127 Soluble aggregates ND
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passed our initial filters for zinc coordination and hydrogen bond
geometry. The increased number of initial hits reflects the increase in
our sample space; the same set of primary residues often has multiple
potential sets of second-shell residues. It quickly became apparent that
this set of constraints strongly favored scaffolds that were mostly β
sheets; these designs were common in our initial output and became
further enriched as we further filtered the designs as described in the
Materials and Methods section. Briefly, these filters, included restric-
tions on the predicted change in protein stability, the number of muta-
tionsmade, the rotamers and identities of second-shell residues, buried
unsatisfied polar groups, the geometries of both the zinc coordination
and the designed hydrogen bonds and the secondary structure of first-
and second-shell residues. The filters for rotamer energies and stable
secondary structure were especially restrictive in this respect; while
most filters eliminated <15% of our prospective binding pockets,
these removed 23 and 42% of pockets, respectively. They also re-
moved a large proportion of potential designs, particularly within hel-
ical scaffolds (51 and 59%, respectively); the only filter that eliminated
a larger proportion of designs was our initial filter for buried unsatis-
fied polar groups, which eliminated 64% of potential models. Only
one design with any appreciable alpha helical character was selected
for testing (Table I).
Despite being common in nature (Dudev et al., 2003), we saw very
few designed zinc binding sites with second-shell hydrogen bonds to
backbone carbonyl oxygens. This result may be due to the fact that
RosettaMatch is intended for side chain design and does not allow
backbone flexibility; since the backbone torsion angles of these resi-
dues, even in flexible loop regions, are not allowed to change, we
are far less likely to find matches that include these atoms. The major-
ity of second-shell residues in our initial matches were aspartate,
Fig. 2 (A) Predicted structure of ZE2 zinc binding site. (B) Crystal structure of ZE2 zinc binding site. (C) Crystal structure of ZE2 overlaid with the design model.
Although the predicted residues do form the zinc binding site, the histidines (along with the zinc ion) have shifted their positions to form stabilizing hydrogen
bonds with surrounding residues. H210 (bottom center) has changed rotamers to form a hydrogen bond with the side chain of E50; H179 (left) has changed
rotamers to form a hydrogen bond with N160 and is coordinating the zinc ion with the epsilon nitrogen instead of the delta nitrogen; and the loop containing
H183 (top center, far right) has moved over 9 Å to accommodate the new position of the binding site. (D) ZE2 is well folded in the absence of zinc. (E) ZE2
shows increased thermal stability in the presence of saturating zinc, which increases the thermal transition temperature from 90.2 to 92.4°C. (F) ZE2 binds zinc
in the designed site with 1.4 µM affinity as measured by ITC. A second nonspecific binding event (KD = 92 µM) is also observed by ITC, but only the first site
appears in the crystal structure.
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asparagine, glutamate and glutamine; however, due to our restrictions
on both the number of second-shell glutamates/glutamines and buried
unsatisfied polar groups in the second shell (since these groups intro-
duce an extra polar atom requiring a hydrogen bond partner), serine
and threonine hydrogen bond partners were slightly enriched during
the filtering process. We also favored hydrogen bonds to serine and
threonine during our manual screen of designs. Figure 3B shows ex-
amples of designed zinc binding sites chosen for experimental testing.
Six of the seven Phase 2 designs tested were solubly expressed as
fusions to maltose binding protein (MBP). However, all of these six
designs either formed soluble aggregates as fusion proteins or aggre-
gated immediately upon MBP cleavage (Table I). When expressed
with no MBP fusion, only designs 255 and 339 were detected in the
soluble fraction of bacterial lysates, and they continued to form sol-
uble aggregates; these problems persisted with low expression tem-
peratures and exogenous zinc.
We reasoned that the mutations we made in these designs, many of
which were on β strands, may have disrupted β sheet assembly and pre-
vented them from folding properly. Althoughmost of these designs did
score slightly worse in the absence of zinc than their starting scaffolds,
two of the proteins that formed soluble aggregates (548 and 289) were
predicted to be stabilized. However, 48% of the mutations made in
these designs converted a hydrophobic or aromatic residue to a
polar or charged residue (Table I). We reasoned that if we lifted our
Fig. 3 Sample models of designed zinc binding sites showing coordinating residues and hydrogen bonding residues. (A) Phase 1 sites include three histidines or
cysteines with no designed second-shell residues. (B) Phase 2 sites add two second-shell hydrogen bonding residues. (C) Phase 3 sites introduce liganding Asp/Glu
and relaxed secondary-structure requirements to increase site variability.
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requirement on binding site secondary structure, we could potentially
avoid making these destabilizing mutations to the protein core and we
may also increase our scaffold diversity to include more proteins with
helical secondary structure.We also reasoned that increasing the diver-
sity of our potential binding sites by allowing alternative coordinating
residues would give us a larger set of designs to select from that passed
our selection criteria and allow us to be more stringent in our filter for
protein stability. Therefore, in our next design round, we allowed acid-
ic coordinating residues and lifted our requirement that the majority of
ligand residues be placed on stable secondary-structure elements.
Fig. 4 (A) Designmodel for Hinge2. The predicted binding site is composed of two histidines and one aspartate. Stabilizing hydrogen bondswere designed for two of
the residues. (B) Comparison of zinc binding measurements for Hinge2 and point mutants of its three zinc-coordinating residues (H256A, H110A, E261A) and two
hydrogen bond partners for those residues (D16A, E154A). All mutants show decreased affinity for zinc. The H256A mutation abolishes zinc binding. N/A, not
applicable. (C and D) Sample ITC data for Hinge2 (C) and its D16A mutant (D).
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While our efforts to increase diversity in our designs did give us
a varied pool of starting structures, their scaffold diversity quickly
deteriorated during filtering. The initial RosettaMatch run generated
2 868 308 potential binding sites in 54 scaffolds. After applying initial
filters for zinc site geometry and eliminating models containing
clashes, we produced 95 318 starting designs in 47 scaffold proteins
across all scaffold types. After applying all filters, however, 12 of
these scaffolds were eliminated, 11 of which were mixed α/β scaffolds.
Of the 549 remaining designs, 448 of them were in mostly-beta scaf-
folds (lipocailin, jelly roll or beta propeller folds). To ensure that de-
signs with helical character were still represented in our test set, we
chose 1–3 designs from each scaffold type excluding beta propellers,
which were considerably larger than our other scaffolds. The selected
designs are summarized in Table I, and examples of binding sites from
selected designs are shown in Fig. 3C.
Of the 12 selected designs expressed with N-terminal polyhistidine
tags, 6 failed to express and 3 formed soluble aggregates similar to
those seen in Phase 2 (Table I). Notably, all of the proteins in β
sheet scaffolds (lipocailin or jelly roll) either failed to express or
formed soluble aggregates. The three remaining designs, which did ex-
press successfully, were all in α/β scaffolds with binding sites primarily
located on loops rather than on stable secondary-structure elements.
Using ITC, we determined that these three designs all bind zinc with
the 1:1 stoichiometry that we predicted; however, all of their affinities
were substantially lower than those typically found in naturally occur-
ring zinc binding proteins (Table I). TIM1 was found to have a very
low zinc affinity (>30 µM) and expressed at very low levels, whereas
the two designs in periplasmic binding protein scaffolds (Hinge1 and
Hinge2) bound somewhat more tightly (KD = 6.5 and 1.1 µM, respect-
ively). Hinge2 was also found to be stabilized in the presence of zinc
(Fig. 4B), whereas both TIM1 and Hinge1 showed no change in sta-
bility. Since it had the highest zinc affinity of the three, we focused on
Hinge2 for further characterization.
We next determined the zinc affinities of alanine point mutations of
the three coordinating and two second-shell residues of Hinge2 by ITC
(Fig. 4B–D). Mutation of H256 leads to a complete elimination of zinc
affinity as evidenced by both a lackof binding on ITC and a lackof ther-
mal stabilization in the presence of zinc. Mutation of H110 leads to a
substantial (∼10-fold) decrease in zinc affinity; however, the other three
mutations lead to little change in affinity (∼1.6- to 3-fold decrease)
(Fig. 4B). Overall, the data suggest that H256 and H110 participate
in zinc binding; however, the remaining three point mutants (E261A,
D16Aand E154A) show little change in zinc affinity. Therefore, we can-
not conclusively say that the site is formed as predicted.
The flexibility of the protein backbone at the zinc binding site may
have contributed to differences in its metal coordination. Natural zinc
Fig. 5 Crystal structure of Spelter (Der et al., 2013) compared with design model. (A) The modeled zinc binding site includes two cysteines and a histidine from
Spelter in addition to a residue from ubiquitin. (B) Overlay of design model and crystal structure. The designed zinc binding site (foreground) does not form. (C)
An additional unmodeled zinc binding site was formed due to a mutation (V122E) made to increase stability during the design process.
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binding sites favor ligand residues that are stabilized on secondary-
structure elements, especially beta strands (Vallee and Auld, 1990;
Mccall et al., 2000). Unfortunately, in our experience, protein scaffolds
are less able to tolerate mutations in these positions, making many
of the most promising metalloprotein designs difficult to express and
purify.
In this case, the scaffold chosen for our designs is also known to
undergo conformational changes upon ligand binding; binding of
the natural ligand stabilizes proteins of this family in the closed con-
formation, which we used in our design models (Dwyer et al., 2003;
Narunsky et al., 2015). Although our zinc binding site is near the ori-
ginal ligand binding site, we did not explicitly model the open con-
formation of our scaffold; therefore, the binding site likely takes on
multiple conformations, and some of these alternate conformations
may also be able to coordinate zinc in unexpected ways.
Unfortunately, possibly due to the issues discussed above, we have
not yet been able to obtain a crystal structure of Hinge2 to confirm the
geometry of its binding site. Our experiences with other designs have
demonstrated that biophysical characterization will not necessarily re-
veal the geometry of a zinc binding site. In a 2013 study, Der et al. de-
scribe Spelter, a designed protein which was intended to form a zinc
binding site at an interface with ubiquitin (Der et al., 2013). However,
when we attempted to co-crystallize Spelter and ubiquitin, the result-
ing crystal structure did not contain ubiquitin. Instead, molecular re-
placement with two copies of Spelter’s starting scaffold (PDB ID
2D4X) yielded a crystal structure with 1.7 Å resolution. As the de-
signed zinc binding site occurs at the interface between Spelter and
ubiquitin, this was a strong indication that the metal binding site
was most likely not forming as we originally predicted. Indeed, despite
extensive validation, including testing zinc binding to a variant revert-
ing all mutations except the residues in the designed binding site to
wild type, the crystal structure of Spelter does not show zinc binding
at the designed site; the histidine (H192) and one of the cysteines
(C137) predicted to participate in zinc binding have changed rota-
mers, and the loop containing the two cysteines (C135 and C137)
has changed conformation resulting in a 2 Å movement in the alpha
carbon of C135. Instead, a zinc ion is bound at a nearby site composed
of two wild-type residues (H125 and E200) and one mutation
(V122E) that was made for stability (Fig. 5). As in the case of ZE2,
this difference may be partially explained by the lack of designed
second-shell interactions in the zinc binding site. Cysteines in natural
structural zinc binding sites typically interact with main-chain amide
groups (Supplementary Fig. S2B); these interactions are not present in
Spelter’s designed zinc binding site (Supplementary Fig. S2A). In the
crystal structure of Spelter, these cysteines have changed rotamers so
that their side chains interact with neighboring backbone amide
groups. H192 has likewise changed rotamers to form pi-stacking inter-
actions with a nearby tryptophan.
Conclusion
Although several studies, including this one, have succeeded in design-
ing sites that bind the desired metal, our results indicate that further
advancements in computational metal binding site design methods
will be necessary to design these sites with the precision necessary to
achieve native-like affinity, specificity and function.
To solve this problem, it will be necessary to more carefully con-
sider other factors in metal coordination that were not accounted for
in this or previous studies. For instance, we did not directly take into
account the electrostatic environment of the designed zinc binding
sites, which can affect both their affinities and their functions. For
instance, sites containing negatively charged residues stabilize the
positive charge on zinc ions; while this increases their affinity for
zinc, it simultaneously decreases the ion’s catalytic activity by reducing
its ability to activate water molecules (Dudev and Lim, 2008).
Furthermore, we did not explicitly design a stabilizing hydrogen
bond partner for such a water molecule; naturally occurring zinc en-
zymes such as carbonic anhydrase II typically have such an interaction
(Christianson and Fierke, 1996). Although we did test to ensure that
our designs did not contain buried unsatisfied polar atoms, we did not
explicitly design additional interactions; the presence of a larger
hydrogen bond network may improve the success of this approach.
Although we did perform backbone minimization during the re-
finement of our designs, backbone flexibility was not allowed during
the initial search for binding sites and was limited throughout the
protocol. Therefore, our search space was somewhat limited; in par-
ticular, it was difficult for us to find potential second-shell hydrogen
bonds to backbone atoms, and we could not detect potential conform-
ational changes caused by our mutations (such as those seen in the
crystal structure of ZE2). Future techniques that take into account
these effects on both the immediate environment of the site and the
scaffold as a whole will be necessary to consistently achieve accurate
design of these sites.
Supplementary data
Supplementary data are available at PEDS online.
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